Veterinarian Prescription (Rx) Required
Free Shipping on orders over $75
Low Price Match Guarantee
Vetmedin is indicated for use with concurrent therapy for congestive heart failure (e.g., furosemide, etc.) as appropriate on a case-by-case basis.
a. A dog with modified New York Heart Association (NYHA) Class II heart failure has fatigue, shortness of breath, coughing, etc. apparent when ordinary exercise is exceeded.
b. A dog with modified NYHA Class III heart failure is comfortable at rest, but exercise capacity is minimal.
c. A dog with modified NYHA Class IV heart failure has no capacity for exercise and disabling clinical signs are present even at rest.
Pimobendan enhances cardiac muscle contractility and dilates blood vessels, thereby improving heart efficiency and reducing the workload on the heart.
Pimobendan, a benzimidazole-pyridazinone derivative, functions as a non-sympathomimetic, non-glycoside inotropic agent with vasodilative properties.
VETMEDIN Solution is intended for use only in dogs with clinical evidence of heart failure. It should not be administered in cases of hypertrophic cardiomyopathy, aortic stenosis, or any condition where increasing cardiac output is inappropriate.
Common side effects observed in field studies include poor appetite, lethargy, diarrhea, difficulty breathing, azotemia, weakness, and ataxia.
Keep this medication out of reach of children. In case of accidental ingestion, seek medical advice immediately.
Only for use in dogs with clinical evidence of heart failure. At 3 and 5 times the recommended dosage, administered over a 6-month period of time, pimobendan caused an exaggerated hemodynamic response in the normal dog heart, which was associated with cardiac pathology.
Not for use in humans. Keep this and all medications out of reach of children. Consult a physician in case of accidental ingestion by humans.